AGING AND ALZHEIMER DEMENTIA--ROLE OF FIBROUS PROTEIN
衰老和阿尔茨海默氏痴呆——纤维蛋白的作用
基本信息
- 批准号:3114975
- 负责人:
- 金额:$ 26.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-05-01 至 1996-04-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer's disease SDS polyacrylamide gel electrophoresis aging antibody autoradiography calcium flux calmodulin dependent protein kinase chemical cleavage embryo /fetus cell /tissue enzyme linked immunosorbent assay fibrous protein gel electrophoresis genetic manipulation glutamates hippocampus histopathology human genetic material tag human tissue immunocytochemistry laboratory rabbit laboratory rat mass spectrometry molecular cloning molecular pathology neurochemistry neurofibrillary tangles neurons paired helical filament pathologic process phosphorylation postmortem posttranslational modifications protein kinase protein kinase A protein kinase C protein sequence tau proteins tissue /cell culture western blottings
项目摘要
The long-term goal of this project is the understanding of the biology and
molecular pathogenesis of Alzheimer's disease (AD), the most common organic
dementia seen in old age. AD is characterized by the presence of
neurofibrillary tangles which consist primarily of paired helical filaments
(PHF). PHF preparations contain aberrant forms of tau named epitopes but
differed in reactivity with a monoclonal anti-tau antibody (Tau-1) and
antibodies to a region of bovine tau encoded by tau gene exon 2. A
pretreatment of PHF-tau with phosphatase improved its binding with these
antibodies, suggesting that PHF-tau differed from normal tau in the site/or
the extent of phosphorylation. We have shown recently that PHF-tau also
differed from normal tau in molecular mass and isoelectric charge.
Dephosphorylation had very little effect on the biochemical properties of
PHF tau, suggesting that post-translational modifications, besides
phosphorylation, and/or alternative gene splicing play a role in the
formation of PHF-tau. It remains to be determined if PHF-tau, besides the
two regions mentioned above, contain other aberrant regions, and if
phosphorylation is the only biochemical modification that distinguishes
PHF-tau from normal tau. It is also unknown if PHF-tau contains additional
phosphorylation sites and if the aberrant phosphorylation of PHF-tau is
catalyzed via a protein kinase (s) in normal brains or only in AD brains.
These questions will be answered by comparing PHF-tau, and tau proteins
from normal and AD brains for their phosphate content, amino acid
composition and sequences, post-translational modifications and by studying
the rephosphorylation of dephosphorylated PHF-tau with known kinases and
kinases from brain homogenates. A subtoxic level of glutamate or calcium
ionophore A23187 was recently shown to alter the immunoreactivity of tau in
cultured neurons. It is unclear whether this alteration is similar to that
in PHF-tau. Our last specific aim is to study the effect of these
treatments on the biochemical and immunocytochemical properties of tau, and
on the ultrastructure of the affected neurons.
这个项目的长期目标是了解生物学和
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHU-HUI C YEN其他文献
SHU-HUI C YEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHU-HUI C YEN', 18)}}的其他基金
Biochemistry and Cell Biology of alpha-Synucleinopathies
α-突触核蛋白病的生物化学和细胞生物学
- 批准号:
6842193 - 财政年份:2004
- 资助金额:
$ 26.39万 - 项目类别:
MECHANISMS OF TAU PATHOGENSIS IN A CELL MODEL OF TAUOPATHY
TAU 病变细胞模型中 TAU 发病机制
- 批准号:
6878765 - 财政年份:2004
- 资助金额:
$ 26.39万 - 项目类别:
PATHOBIOLOGY OF NEURODEGENERATIVE DISEASES LINKED TO TAU GENE MUTATIONS
与 TAU 基因突变相关的神经退行性疾病的病理学
- 批准号:
6338597 - 财政年份:2000
- 资助金额:
$ 26.39万 - 项目类别:
PATHOBIOLOGY OF NEURODEGENERATIVE DISEASES LINKED TO TAU GENE MUTATIONS
与 TAU 基因突变相关的神经退行性疾病的病理学
- 批准号:
6205226 - 财政年份:1999
- 资助金额:
$ 26.39万 - 项目类别:
AGING BRAIN--IMMUNOHISTOLOGY AND BIOCHEMISTRY
大脑老化——免疫组织学和生物化学
- 批准号:
2442201 - 财政年份:1993
- 资助金额:
$ 26.39万 - 项目类别: